Eshmoun Clinical-Research expresses its academic commitment by publishing the results of the 1st survey of its kind on the perception of Tunisian citizens regarding their participation in clinical trials.
Article (2019) vol 97 n°04, published in La Tunisie Médicale.
#Eshmoun #Scientificpaper #ClinicalTrials #survey #investigation
(02/10/2019) “Interest of observational studies, in health policy strategy and in the life of medicines: Contribution of CROs.”, Intervention by Dr Chokri Jeribi at the 8th edition of Maghreb pharma expo 2019 in Algiers
Tunisia, Algeria and Morocco determined to collaborate to help boost Clinical Research in the Maghreb.
#Eshmoun #ClinicalResearch #bioequivalence #maghrebpharma #Tunisia #Algeria #MENA #healthpolicy
CVCT MEMA is one of the most unique conferences, a combination of investigators, young researchers, and regulators in a very interactive setting. CVCT MEMA is more than classic meetings, it’s a think tank meeting that covers 2 independent focuses. One day is dedicated to reviewing the findings of all major advances in cardiovascular (CV) trials and how to adapt them to the local healthcare systems. And one full day “regulatory summit” assembles all regional key stakeholders aiming at upscaling clinical research in the Region, promoting the production of reliable healthcare knowledge, much needed for all decision makers. CVCT MEMA assembles major regulatory bodies and IRBs representatives in many selected countries of the Region. It involves CROs and industry representatives as speakers and/or panelists.
During CVCT 2019, a Full day “Regulatory Summit” was held and involved key officials from regulatory agencies in the region, as well as from the European Medicine Agency (MEA) and the US Food and Drug Administration (FDA), governments’ officials, major pharma and CROs, members of ethics committees, international advisors and key experienced investigators.
#EMA #FDA #MENAJFDA #SaudianFDA #Egypt #Tunisia #UAE #ClinicalResearch #ClinicalTrials #Thinktank #Harmonisationregulatoryframework
The CEO of Eshmoun-Clinical Research, Dr Souad Dziri, was the guest speaker at the first International Congress of the Tunisian Society of Pharmacy and Oncology to discuss the role of CROs in setting up clinical trials during the second session of the day on the theme of Clinical Research in Oncology.
